Darunavir

Darunavir is a prescription medication used as part of antiretroviral therapy to treat human immunodeficiency virus type‑1 (HIV‑1) infection in children (≥3 years of age) and adults. Darunavir is a protease inhibitor that blocks an HIV enzyme essential for viral replication. This helps lower the viral load and boost immune function when taken with other HIV medicines like ritonavir or cobicistat.

Darunavir must be used under the supervision of a licensed doctor/healthcare provider experienced in managing HIV. While it does not cure HIV, it may significantly improve immune health, reduce the risk of complications, and help patients maintain long‑term viral suppression.

For individuals in the U.S. seeking affordable treatment options, licensed Canadian pharmacies can sometimes provide cost‑effective access with a valid prescription. This helps manage long‑term HIV care without excessive pricing.

• Darunavir FDA-approved Indication: Treatment of HIV‑1 infection in:
• Adults: When used in combination with other antiretroviral agents and a pharmacokinetic enhancer (such as ritonavir or cobicistat).
• Pediatric patients (≥3 years old): When used in combination with other antiretroviral agents and a pharmacokinetic enhancer.
• Darunavir is an FDA‑approved antiretroviral medication (HIV‑1 protease inhibitor) that must be taken with a boosting agent (e.g., ritonavir) and other antiretrovirals.

Darunavir is an HIV-1 protease inhibitor that works by blocking the activity of the HIV-1 protease enzyme.

Darunavir Mechanism of Action:

• HIV-1 protease is an enzyme required for the cleavage of viral polyprotein precursors into functional viral proteins.
• Darunavir binds to the active site of the HIV-1 protease enzyme.
• This inhibition prevents the formation of mature, infectious HIV-1 virions.
• As a result, the virus produced is immature and non-infectious, reducing viral replication in the body.

Darunavir must be taken with a pharmacokinetic enhancer (such as ritonavir or cobicistat) and in combination with other antiretroviral agents. This helps in maintaining effective drug levels and suppressing HIV-1 replication.

Hepatotoxicity

• Severe and potentially life-threatening liver problems (including fatal cases) have been reported in patients taking Darunavir.
• People with underlying liver disease (including hepatitis B or C) have an increased risk of developing worsening liver function.
• Liver function tests should be performed before starting therapy and monitored during treatment.

Severe Skin Reactions

• SJS (Stevens‑Johnson syndrome), TEN (toxic epidermal necrolysis), and DRESS (drug rash with eosinophilia & systemic symptoms) have been reported.
• Discontinue immediately if a severe rash develops.

Do not take Darunavir 800 mg tablets if you:

• Have a known hypersensitivity (e.g., severe skin reactions) to Darunavir or any of its ingredients.
• Are taking medicines contraindicated with Darunavir due to serious or life‑threatening reactions or loss of virologic response
  • These include certain drugs highly dependent on CYP3A for clearance or strong CYP3A inducers (rifampin, St. John’s Wort).

• Sulfonamide Allergy: Darunavir contains a sulfonamide moiety; use caution in patients with sulfa allergy.
• Diabetes/Hyperglycemia: New onset or worsening diabetes and hyperglycemia have been reported.
• Immune Reconstitution Syndrome: May occur after initiation of antiretroviral therapy.
• Fat Redistribution: Changes in human body fat distribution may occur with antiretroviral therapy.
• Hemophilia: Increased bleeding episodes have been reported in people with hemophilia type A and B treated with protease inhibitors.
• Drug Interactions: Darunavir is metabolized by CYP3A; use caution with concomitant medications.

Darunavir may cause side effects. This is not a complete list of all possible Darunavir side effects. Contact your doctor right away if you experience any severe or unusual symptoms.

Here are general administration guidelines on how to take Darunavir tablets for HIV‑1 infection treatment:

• Take Darunavir with food. Food increases absorption and ensures proper drug levels in the body.
• Darunavir must be taken with a boosting agent (ritonavir or cobicistat).
• It may be taken once daily or twice daily, depending on treatment history and resistance profile.
• Swallow Darunavir tablets whole; do not crush or chew unless advised by your healthcare provider.
• If a Darunavir dose is missed, follow your healthcare provider’s instructions and do not double the next dose.

The following dosage information provides general recommended dosing guidelines for Darunavir (Prezista). Dosage may vary based on treatment history, resistance profile, body weight, and other medical conditions. Always consult your provider for individualized dosing and medical advice.

Recommended Darunavir Dosage in Adults

Recommended Darunavir Dosage in Pediatric Patients (≥3 Years of Age)

Darunavir must be administered with ritonavir and taken with food. Dosing is based strictly on body weight.

Treatment-Naïve or Treatment-Experienced (Without Darunavir Resistance-Associated Mutations)

Important Information for Pediatric Patients (≥3 Years of Age)

• Do not use once-daily dosing in pediatric patients with darunavir resistance-associated mutations.
• Pediatric dosing differs for children with resistance mutations (requires twice-daily 600 mg dosing with ritonavir).Always follow the full prescribing information chart for exact weight-based calculations.
  

• Human experience with an acute overdose of Darunavir is limited.
• There is no specific antidote for Darunavir overdose.
• Treatment of overdose consists of general supportive measures, including monitoring of vital signs and observation of the patient’s clinical status.
• If you suspect a Darunavir overdose, contact your healthcare provider immediately or call your local Poison Control Center (1-800-222-1222).

Darunavir may interact with certain medications. Because Darunavir is metabolized by the CYP3A enzyme system and is used with a pharmacokinetic enhancer (ritonavir or cobicistat), significant drug interactions can occur. Tell your provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Contraindicated Darunavir Drug Interactions

Drugs Requiring Caution or Dose Adjustment

If Darunavir isn’t appropriate, your provider may consider other prescription-only alternative medications. The right alternative depends on your age, underlying condition, and how your body responds. Always discuss options with a specialist before making changes.

• Reyataz (atazanavir)
• Kaletra (lopinavir + ritonavir)
• Aptivus (tipranavir)
• Crixivan (indinavir)
• Viracept (nelfinavir)
• Norvir (ritonavir)
• Invirase (saquinavir)

Many patients choose to order Darunavir from Canada because it is often more affordable than U.S. retail prices. At Polar Bear Meds, we source our medications from a network of licensed Canadian and international pharmacies that follow strict dispensing regulations. When you buy Darunavir online from our pharmacy, you can save 80–90%, which may be more affordable than U.S. retail rates.

Buying Darunavir from Canada requires a valid prescription from a licensed medical provider. You can also enjoy several savings programs, including:

• Darunavir coupon to get 10% off your first order.
• Competitive pricing
• Referral programs

Yes. Polar Bear Meds ships prescription medications from Canada to customers in the U.S. with a valid prescription from a licensed healthcare provider.

To place an order, customers must provide a valid prescription. Once approved, orders are typically processed promptly and delivered within 3–5 business days via Xpress Post.

Polar Bear Meds also provides a tracking ID so you can track your order and receive authentic, properly sourced medications.

For specific medication availability, shipping timelines, or documentation requirements, customers should contact our pharmacy team directly.

The information provided about Darunavir is for general educational purposes. Polar Bear Meds does not replace a diagnosis, medical advice, or treatment. Darunavir is a prescription medication used for HIV‑1 infection treatment and should be used only under the supervision of a licensed healthcare provider. Always consult your provider before starting or discontinuing any medication.

• https://medlineplus.gov/druginfo/meds/a607042.html
• https://www.mayoclinic.org/drugs-supplements/darunavir-oral-route/description/drg-20069827
• https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021976s045_202895s020lbl.pdf